AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020
Feb 5, 2020
30583_dirs_2020-02-04_50d26748-428a-480f-b761-16e495e250ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-10-31
Reporting Person: Mueller Brian (SVP, Acting CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-31 | Common Stock | A | 9 | $62.229 | Acquired | 13968 | Direct |
| 2020-02-03 | Common Stock | A | 5800 | — | Acquired | 19768 | Direct |
Footnotes
F1: Represents shares acquired by the reporting person on October 31, 2019, pursuant to the issuer's Employee Stock Purchase Plan.
F2: Restricted stock units granted on February 3, 2020. Price not applicable.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19